Related Experiment Video
Updated: Oct 8, 2025

04:59
Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases
Published on: June 20, 2025
381
Targeting regulated cell death in aortic aneurysm and dissection therapy
1Division of Cardiothoracic and Vascular Surgery, Sino-Swiss Heart-Lung Transplantation Institute, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Pharmacological Research
|December 30, 2021
Summary
Regulated cell death (RCD) plays a key role in aortic aneurysm and dissection (AAD). Understanding novel RCD types like ferroptosis and pyroptosis offers new therapeutic strategies for AAD.
Area of Science:
- Cell Biology
- Pathology
- Cardiovascular Research
Background:
- Regulated cell death (RCD) is crucial for tissue homeostasis.
- Novel RCD types, including ferroptosis and pyroptosis, have been recently defined.
- The pathogenesis of aortic aneurysm and dissection (AAD) remains incompletely understood.
Purpose of the Study:
- To review the roles of various regulated cell death types in AAD.
- To provide a framework for understanding RCD's involvement in AAD.
- To highlight potential therapeutic strategies targeting RCD in AAD.
Main Methods:
- Literature review of studies on RCD and AAD.
- Analysis of existing research on cell death mechanisms in AAD pathogenesis.
- Synthesis of information on in vitro and in vivo interventions for AAD.
Main Results:
- Cell death of smooth muscle cells, endothelial cells, and inflammatory cells contributes to AAD development.
- Interventions targeting cell death pathways show promise in alleviating AAD progression.
- Various RCD types are implicated in the molecular mechanisms of AAD.
Conclusions:
- Regulated cell death is a significant factor in AAD pathogenesis.
- Targeting specific RCD pathways presents a promising therapeutic avenue for AAD.
- Further research into RCD mechanisms can elucidate AAD's molecular underpinnings.
Related Concept Videos
Aneurysm III: Interprofessional Care
47
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
47
Aortic Regurgitation III: Medical Management
65
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
65
Peripheral Artery Disease III: Interprofessional Care
48
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
48

